This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
Award recognizes innovation, financial performance, and commitment to business and community
Scottsdale, AZ (PRWEB) May 13, 2012
QualityStocks would like to highlight CytoSorbents Corporation, a publicly traded company focused on critical care, using blood purification to treat life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Each polymer bead contains millions of pores and channels that can be modified to remove substances as small as drugs, to substances as large as antibodies.
In the company’s news last week,
CytoSorbents announced its CEO, Dr. Phillip Chan, was named as a finalist in the Ernst & Young Entrepreneur Of The Year® 2012 program, which recognizes entrepreneurs with demonstrated success in areas such as innovation, financial performance, and personal commitment.
Dr. Chan was selected by an independent judging panel comprised of previous winners, CEOs, private capital investors, and other regional business leaders.
Since his appointment as CytoSorbents CEO and president in 2009, Dr. Chan has taken initiatives to build the company into an emerging pioneer of advanced blood purification technologies, and is currently guiding the company through the transition from a development-stage company into an early commercialization stage company through the approval and early sales of its flagship product, CytoSorb®, in the EU.
As a board-certified internal medicine physician, Dr. Chan previously led healthcare and life science investments as Partner for the $80M NJTC Venture Fund and co-founded Andrew Technologies, a venture-backed medical device company.
Dr. Chan completed his residency at Harvard Medical School at the Beth Israel Deaconess Medical Center; received his MD/PhD from Yale University School of Medicine; and received his bachelor of science in cell and molecular biology with honors and distinction from Cornell University.
Awards will be presented at a special gala on June 27, 2012, at the Hyatt New Brunswick.
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit http://www.QualityStocks.net
To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage
To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/5/prweb9502589.htm